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Abstract 
Randomized clinical trials are acknowledged as the most appropriate methodology for 
demonstrating the efficacy or effectiveness of one intervention as opposed to another and thus play 
a major role in clinical decision making. However, it is recognized that despite the existence of 
various guidelines, for example, the Consolidated Standards for Reporting Trials (CONSORT) 
statement, the quality of manuscripts describing randomised trials is often suboptimal. The current 
project aims to develop and disseminate new guidelines, Preferred Reporting Items for 
RAndomized Trials in Endodontics (PRIRATE), to improve the planning and reporting quality of 
randomized trials in the field of Endodontics. The project leads (VN, PD) designed a robust process 
to develop the PRIRATE guidelines. At first, a steering committee of eight members, including 
the project leads, was formed. Thereafter, a five-stage consensus process will be followed:  Initial 
steps, Pre-meeting activities, Face-to-face consensus meeting, Post-meeting activities and Post-
publication activities. The steering committee will develop the first draft of the PRIRATE 
guidelines by identifying relevant and important items from various sources including the 
CONSORT guidelines and the Clinical and Laboratory Images in Publications (CLIP) principles. 
This will be followed by the establishment of a PRIRATE Delphi Group (PDG) consisting of 30 
members. The individual items of the first draft of the PRIRATE guidelines developed by the 
steering committee will be evaluated and scored on a 9-point Likert scale by the PDG members. 
Items with a score of seven and above by more than 70% of PDG members will be included in the 
second draft of the guidelines and the Delphi process will be repeated until each item fulfils the 
set conditions. After obtaining consensus from the PDG, the PRIRATE guidelines will be 
discussed by 20 selected individuals within a PRIRATE Face-to-face Consensus Meeting Group 
(PFCMG) to arrive at a final consensus. The final PRIRATE guidelines will be accompanied with 
an explanation and elaboration document developed by the steering committee and approved by 
six members, three from the PDG and three from the PFCMG. The PRIRATE guidelines will be 
published in journals and actively disseminated to educational institutions, national and 
international academic societies and presented at scientific meetings.  
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Introduction 
Evidence-based dentistry that includes research-informed healthcare requires both clinicians and 
patients to make clinical decisions based on the best available evidence (Antoniou et al. 2013). In 
the traditional model of evidence-based dentistry, the process of generating evidence largely 
begins with randomized clinical trials (RCTs), due to their ability to avoid bias (systematic error) 
when comparing the respective value of the two or more treatment modalities (Brocklehurst et al. 
2017). RCTs have been considered as the hallmark for demonstrating the efficacy or effectiveness 
of an intervention in health sciences (Juni et al. 2001).  The findings of homogeneous RCTs are 
then pooled statistically by conducting meta-analyses that lay at the pinnacle of the hierarchy of 
evidence (Ismail et al. 2004, Dhar 2016). This distilled and synthesised evidence then forms the 
foundation to create evidence-based guidelines and policies providing accessible data to support 
informed decision-making (Dhar 2016, Lucena et al. 2017). However, RCTs are often subject to 
bias if they have weak study designs, retrospective power calculations and/or poorly reported 
methodological standards, such as unclear description of the sampling or randomization 
procedures, blinded interventions or evaluation of outcome measures. A transparent, 
comprehensive and detailed requirement on reporting of RCTs helps researchers plan their trials 
more effectively and allows readers to understand the findings and their relevance. Additionally, 
this clarity is also crucial to allow extraction of relevant data during subsequent systematic reviews 
and meta-analyses. Moher et al. (1998) explored the effects of the reporting quality of RCTs on 
quantitative results and discovered that studies of low quality were associated with an increased 
estimate of benefit of 34% when compared to high quality trials. Such an overestimation of the 
effectiveness of a RCT may impair the quality of subsequent systematic reviews and meta-
analyses, as well as create difficulties when making decisions regarding dental treatments (Schulz 
et al. 1995).  
 
RCTs generally provide information on the superiority (and less commonly equivalence or 
non-inferiority) of one clinical intervention compared with another. To ensure the accuracy of such 
trials, it is imperative that reporting guidelines and standards are employed that can reduce or 
eliminate bias. Several guidelines have been developed to assure the quality of RCTs, for example, 
the Consolidated Standards for Reporting Trials (CONSORT) statement (Moher et al. 2010) and 
the SPIRIT statement (Chan et al. 2013). The CONSORT statements are the most widely used, 
frequently endorsed and well reported in the literature. It has been reported that the CONSORT 
statements have improved the quality of RCTs in the medical and dental fields (Kane 2007, Vere 
& Joshi 2011, Lucena et al. 2017). Furthermore, a number of complementary guidelines have been 
developed by modifying the CONSORT statements to specific medical specialties, such as 
infertility treatments (Improving the Reporting of Clinical Trials of Infertility Treatments 
(IMPRINT)) (Harbin Consensus Conference Workshop Group 2014), herbal interventions 
(Gagnier et al. 2016), and acupuncture (STandards for Reporting Interventions in Clinical Trials 
of Acupuncture (STRICTA)) (MacPherson et al. 2010). Indeed, the STRICTA guidelines have 
been officially endorsed by the CONSORT group. 
 
The CONSORT statement covers the majority of the essential components for the reporting 
of RCTs in Endodontics and is officially recommended by leading dental journals; however, 
several items, including a list of keywords, a rationale for the selected period of review, details of 
preoperative diagnostic tests, the strength of the RCT and implications of the work on future 
research and clinical practice are missing. Furthermore, endodontic studies can be particularly 
challenging when attempting to ‘blind’ participants, operators and evaluators, and more detail on 
blinding is required than is currently contained within the CONSORT checklist.  In addition, 
Endodontics is a subject within which radiographs and/or alternative images are often central to 
the primary and secondary outcome measure and as a result, the absence of guidelines for image 
presentation and reporting is a limitation of the CONSORT statement for reporting RCTs in 
Endodontics. At the same time, Endodontics, as well as other disciplines in Dentistry, should focus 
on patient-related outcomes in a clinical trial and there is a need to identify the data to be collected. 
(Fleming et al. 2016). 
 
 There are no recommendations that guide the reporting of RCTs contextualized to 
Endodontics or indeed include guidance on image quality reporting (Lang et al. 2012). Hence, the 
objective of this protocol is to develop a set of quality guidelines, the Preferred Reporting Items 
for RAndomized Trials in Endodontics (PRIRATE). In a similar manner to the CONSORT 
statement, the PRIRATE guidelines will comprise a checklist and a flow chart that aims to improve 
the quality of planning and reporting RCTs in Endodontics. By creating guidelines bespoke to 
Endodontics, the PRIRATE guidelines will help authors not only improve the quality, 
completeness, accuracy and transparency of randomized trials reported in the literature, but also 
provide a blueprint for trials to be better designed and implemented more effectively. 
Consequently, this will reduce bias in interpreting and implementing the results of RCTs. 
Critically, the hope is that this will benefit dentists and patients to facilitate accurate clinical 
decision-making, and to researchers when conducting unbiased systematic reviews and meta-
analyses. In addition, it is expected that the PRIRATE guidelines will be adopted by all journals 
that publish RCTs in endodontics by being endorsed by journal editors and reviewers to objectively 
evaluate and appraise RCTs during the editorial review process.  
 
Methods 
The PRIRATE guidelines will be developed based on the Guidance for Developers of Health 
Research Reporting Guidelines (Moher et al. 2010). 
 
Phase I: Initials steps   
Following a literature search and extensive discussion, the project leaders (VN, PD) came to the 
conclusion that comprehensive guidelines for the reporting of RCTs in Endodontics were required. 
A steering committee (SC) (PD, VN, HD, LB, TK, EP, SP, JJ), including the project leads, was 
formed to develop a set of draft PRIRATE guidelines through an iterative approach. The draft 
PRIRATE guidelines will be developed by adapting and elaborating the CONSORT statements 
(Moher et al. 2010) and Clinical and Laboratory Images in Publications (CLIP) principles (Lang 
et al. 2012) to the speciality of Endodontics.  
 
Phase II: Pre-meeting activities.  
To improve the PRIRATE guidelines, an online consensus process will be performed with the help 
of a Delphi group. A PRIRATE Delphi Group (PDG) will be formed of individuals who fulfil at 
least one of the following eligibility criteria: published at least one RCT in Endodontics; published 
any reporting guidelines for in vitro / in vivo research; a minimum 15 years of clinical experience 
as an endodontist or general dental practitioner. The SC will identify potential PDG members in 
order to ensure global representation and invite them to participate in the consensus process for 
developing the guidelines. The PDG will consist of 30 members (22 academicians or researchers, 
four clinical Endodontists, two general dental practitioners and two public representatives).. A 
document explaining the Delphi process will be shared with members who will then participate in 
sequential online surveys to gain consensus on the inclusion of the proposed items within the draft 
PRIRATE guidelines. Comments on each item will be independently and confidentially requested 
from the PDG to avoid bias. Each item will be evaluated by the PDG members on its clarity (yes 
or no) and suitability for inclusion using a 9-point Likert scale (1 = ‘definitely not include’ to 9 = 
‘definitely include’). There will be provision for open comments to better understand the scoring 
of each item included in the guidelines (Maher et al. 2015). Items achieving a score of 7 and above 
by at least 70% of PDG members will become eligible for inclusion. Likewise, items will be 
excluded from the checklist if 70% or more participants score any item between 1 and 3. Items 
scored between 4 and 6 will be closely examined and revised based the comments provided by the 
PDG. The sequential surveys will be repeated with any modifications to the text of each item that 
become necessary as a result of the previous round of surveys, until this standard is achieved (Agha 
et al. 2017).  In all subsequent rounds of the Delphi process, the PDG members will be informed 
of progress through summarized results, including the descriptive group statistics for each item 
including percentage distribution, median (with interquartile range) and combined anonymized 
comments. Being more robust to the effect of outliers, reporting the median and inter-quartile 
range will ensure that members will have some indication of the extent of consensus achieved 
(Murphy et al. 1998).  
 
Once the initial consensus on the items within the guidelines is achieved by the PDG, a face-to-
face consensus meeting will be organized. The SC will decide the venue, date and the time of the 
meeting. The SC will select two chairpersons and 18 members to form the PRIRATE face-to-face 
consensus meeting group (PFCMG). The eligibility criteria for the PFCMG will be similar to the 
PDG but with a conscious decision to appoint new individuals, PDG members will be eligible to 
join the PFCMG. In addition, two postgraduate students on Endodontic programmes will be 
identified to provide their views. Following confirmation of the PFCMG members, details of the 
venue, date and time of the meeting will be provided. The PRIRATE checklist, flow chart, results 
of Delphi process, members’ details and agenda of the meeting will be shared with the group at 
least 10 days prior to the meeting.  
 
Phase III: Face-to-face consensus meeting 
Initially, the project leads (PD, VN) will review the objectives of the meeting followed by the 
presentation of the results of the Delphi process and explain the reasons for the inclusion of the 
items in the PRIRATE checklist and the flow chart. Any outstanding issues will also be clarified 
during the meeting. Thereafter, elaboration and explanation of the individual items in the 
PRIRATE checklist and the flow chart will be discussed with the members to finalize the reporting 
guidelines. Finally, a publication strategy, plans for disseminating the guidelines in scientific 
meetings, journal endorsement and adherence to the reporting guideline will be discussed. Notes 
of the discussions will be kept. 
 
Phase IV: Post-meeting activities 
Following the face-to-face meeting, SC members will finalize the PRIRATE guidelines using 
concise, unambiguous and comprehensive wording, taking into account the comments obtained 
from the PFCMG. The guidelines will be supported with an Explanation and Elaboration document 
supplemented with examples of good reporting for each item prepared by the SC and sent to six 
members for final approval, three from the PDG and three from the PFCMG. The PRIRATE 
guidelines and supporting documents will be published in journals and presented at scientific 
meetings. 
 
Phase V: Post-publication activities 
Endorsement of the guidelines by journals will improve the quality of reporting for randomized 
trials. The PRIRATE guidelines also will be freely available on a dedicated website, the Preferred 
Reporting Items for study Designs in Endodontics (PRIDE). The PRIRATE checklist will be 
translated into several languages. Academicians, researchers, journal editors, peer reviewers and 
others will be able to provide feedback on the PRIRATE guidelines either individually to SC 
members or via the dedicated website. Based on the feedback, the project leaders will periodically 
update the PRIRATE guidelines.  
 
References 
Agha RA, Borrelli MR, Vella-Baldacchino M, Thavayogan R, Orgill DP; STROCSS Group (2017) 
The STROCSS statement: Strengthening the Reporting of Cohort Studies in Surgery. International 
Journal of Surgery 46, 198-202. 
 Antoniou GA, Mavroforou A, Antoniou SA, Murray D, Kuhan G, Giannoukas AD (2013) 
Evidence-based medicine in vascular and endovascular practice. Journal of Endovascular 
Therapy 20, 678-83. 
 
Brocklehurst PR, Williams L, Burton C, Goodwin T, Rycroft-Malone J (2017) Implementation 
and trial evidence: a plea for fore-thought. British Dental Journal 222, 331. 
 
Chan AW, Tetzlaff JM, Gøtzsche PC et al. (2013) SPIRIT 2013 explanation and elaboration: 
guidance for protocols of clinical trials. British Medical Journal 346, e7586 
 
Cochrane Website. Available online at https://www.cochrane.org/uk/node/54565 
 
Dhar V (2016) Evidence-based dentistry: An overview. Contemporary Clinical Dentistry 7, 293-
4. 
 
Fleming PS, Koletsi D, O'Brien K, Tsichlaki A, Pandis N (2016) Are dental researchers asking 
patient-important questions? A scoping review. Journal of Dentistry 49, 9-13.  
 
Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C; CONSORT Group (2006) 
Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT 
statement. Annals of Internal Medicine 144, 364-7. 
 
Harbin Consensus Conference Workshop Group; Conference Chairs, Legro RS, Wu X; Scientific 
Committee, Barnhart KT, Farquhar C, Fauser BC, Mol B (2014) Improving the reporting of 
clinical trials of infertility treatments (IMPRINT): modifying the CONSORT statement. Human 
Reproduction 29, 2075-82. 
 
Ismail AI, Bader JD (2004). Evidence-based dentistry in clinical practice. Journal of the American 
Dental Association 135,78-83. 
 
Jüni P, Altman DG, Egger M (2001) Systematic reviews in health care: assessing the quality of 
controlled clinical trials. British Medical Journal 323, 42-6. 
 
Kane RL, Wang J, Garrard J (2007) Reporting in randomized clinical trials improved after 
adoption of the CONSORT statement. Journal of Clinical Epidemiology 60, 241-9. 
 
Lang TA, Talerico C, Siontis GCM (2012) Documenting clinical and laboratory images in 
publications: the CLIP principles. Chest 141, 1626-32.  
 
Lucena C, Souza EM, Voinea GC, Pulgar R, Valderrama MJ, De-Deus G (2017). A quality 
assessment of randomized controlled trial reports in endodontics. International Endodontic 
Journal 50, 237-50. 
 
MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, White A, Moher D; 
STRICTA Revision Group (2010) Revised STandards for Reporting Interventions in Clinical 
Trials of Acupuncture (STRICTA): extending the CONSORT statement. PLoS Medicine 7, 
e1000261. 
 
Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, 
Altman DG (2010) CONSORT 2010 explanation and elaboration: updated guidelines for reporting 
parallel group randomised trials. Journal of Clinical Epidemiology 63, e1-e37.  
 
Moher D, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP (1998) Does quality of 
reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? 
Lancet 352, 609-13. 
 
Moher D, Schulz KF, Simera I, Altman DG (2010) Guidance for developers of health research 
reporting guidelines. PLoS Medicine 16, e1000217. 
 
Murphy MK, Black NA, Lamping DL, McKee CM, Sanderson CFB, Askham J, et al. (1998) 
Consensus development methods, and their use in clinical guideline development. Health 
Technology Assessment 2, 1-88.  
  
Schulz KF, Chalmers I, Hayes RJ, Altman DG (1995) Empirical evidence of bias. Dimensions of 
methodological quality associated with estimates of treatment effects in controlled trials. Journal 
of the American Medical Association 273, 408-12. 
 
Vere J, Joshi R (2011) Quality assessment of randomised controlled trials of dental implant surgery 
and prosthodontics published from 2004 to 2008: a systematic review. Clinical Oral Implants 
Research 22, 1338-45.  
